nach oben

Current Psychiatry Reports

Erschienen in:

01.07.2017 | Anxiety Disorders (A Pelissolo, Section Editor)

Recent Progress in Virtual Reality Exposure Therapy for Phobias: A Systematic Review

verfasst von: Cristina Botella, Javier Fernández-Álvarez, Verónica Guillén, Azucena García-Palacios, Rosa Baños

Erschienen in: Current Psychiatry Reports | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

This review is designed to systematically examine the available evidence about virtual reality exposure therapy’s (VRET) efficacy for phobias, critically describe some of the most important challenges in the field and discuss possible directions. Evidence reveals that virtual reality (VR) is an effective treatment for phobias and useful for studying specific issues, such as pharmacological compounds and behavioral manipulations, that can enhance treatment outcomes. In addition, some variables, such as sense of presence in virtual environments, have a significant influence on outcomes, but further research is needed to better understand their role in therapeutic outcomes. We conclude that VR is a useful tool to improve exposure therapy and it can be a good option to analyze the processes and mechanisms involved in exposure therapy and the ways this strategy can be enhanced. In the coming years, there will be a significant expansion of VR in routine practice in clinical contexts.

McLuhan M. Understanding media. New York, editor. Signet; 1964.

Botella C, Perpiñá C, Baños RM, García-Palacios A. Virtual reality: a new clinical setting lab. Stud Health Technol Inform. 1998;58:73–81.PubMed

Riva G, Mantovani F, Capideville CS, Preziosa A, Morganti F, Villani D, et al. Affective interactions using virtual reality: the link between presence and emotions. CyberPsychology Behav. 2007;10:45–56.CrossRef

Riva G, Botella C, Baños R, Mantovani F, García-Palacios A, Quero S, et al. Presence-inducing media for mental health applications. In: Immersed in media. Cham: Springer International Publishing; 2015. p. 283–332.

Newman MG, Szkodny LE, Llera SJ, Przeworski A. A review of technology-assisted self-help and minimal contact therapies for anxiety and depression: is human contact necessary for therapeutic efficacy? Clin Psychol Rev. 2011;31:89–103.PubMedCrossRef

Botella C, Baños RR, García-Palacios A, Quero S. Virtual reality and other realities. In: Hofmann S, Asmundson G, editors. The science of cognitive behavioral therapy. New York: Academic; 2017.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.PubMedPubMedCentralCrossRef

Opriş D, Pintea S, García-Palacios A, Botella C, Szamosközi Ş, David D. Virtual reality exposure therapy in anxiety disorders: a quantitative meta-analysis. Depress Anxiety. 2012;29:85–93.PubMedCrossRef

Parsons TD, Rizzo AA. Affective outcomes of virtual reality exposure therapy for anxiety and specific phobias: a meta-analysis. J Behav Ther Exp Psychiatry. 2008;39:250–61.PubMedCrossRef

10.

Powers MB, Emmelkamp PMG. Virtual reality exposure therapy for anxiety disorders: a meta-analysis. J Anxiety Disord. 2008;22:561

11.

•• Morina N, Ijntema H, Meyerbröker K, Emmelkamp PMG. Can virtual reality exposure therapy gains be generalized to real-life? A meta-analysis of studies applying behavioral assessments. Behav Res Ther. 2015;74:18–24. The meta-analysis shows the effect size of VRET interventions when laboratory tests are used to measure treatment outcomes. This is important in establishing the extent to which therapeutic gains can be translated into real-life situations PubMedCrossRef

12.

•• Ling Y, Nefs HT, Morina N, Heynderickx I, Brinkman WP. A meta-analysis on the relationship between self-reported presence and anxiety in virtual reality exposure therapy for anxiety disorders. PLoS One. 2014;6:9. This meta-analysis demonstrates the positive relationship between sense of presence and anxiety. Moreover, it shows that this relationship is moderated by different factors

13.

Turner WA, Casey LM. Outcomes associated with virtual reality in psychological interventions: where are we now? Clin Psychol Rev. 2014;34:634–44.PubMedCrossRef

14.

Valmaggia LR, Latif L, Kempton MJ, Rus-Calafell M. Virtual reality in the psychological treatment for mental health problems: an systematic review of recent evidence. Psychiatry Res. 2016;236:189–95.PubMedCrossRef

15.

Chicchi Giglioli IA, Pallavicini F, Pedroli E, Serino S, Riva G. Augmented reality: a brand new challenge for the assessment and treatment of psychological disorders. Comput Math Methods Med. 2015:1–13.

16.

Anderson PL, Price M, Edwards SM, Obasaju MA, Schmertz SK, Zimand E, et al. Virtual reality exposure therapy for social anxiety disorder: a randomized controlled trial. J Consult Clin Psychol. 2013;81:751–60.PubMedCrossRef

17.

Hofmann SG. Cognitive mediation of treatment change in social phobia. J Consult Clin Psychol. 2004;72:393–9.PubMedPubMedCentral

18.

• Botella C, Pérez-Ara MÁ, Bretón-López J, Quero S, García-Palacios A, Baños RM. In vivo versus augmented reality exposure in the treatment of small animal phobia: a randomized controlled trial. PLoS One. 2016;11:1–22. This is the first and only RCT on augmented reality. It shows that the efficacy of augmented reality is equal to that of in vivo exposure in treating small animal phobias CrossRef

19.

Ost LG. One-session treatment for specific phobias. Behav Res Ther. 1989;27:1–7.PubMedCrossRef

20.

Bouchard S, Dumoulin S, Robillard G, Guitard T, Klinger E, Forget H, et al. Virtual reality compared with in vivo exposure in the treatment of social anxiety disorder: a three-arm randomized controlled trial. Br J Psychiatry. 2017;210:276–283.

21.

Czerniak E, Caspi A, Litvin M, Amiaz R, Bahat Y, Baransi H, et al. A novel treatment of fear of flying using a large virtual reality system. Aerosp Med Hum Perform. 2016;87:411–6.PubMedCrossRef

22.

• Kampmann IL, Emmelkamp PMG, Hartanto D, Brinkman W-P, Zijlstra BJH, Morina N. Exposure to virtual social interactions in the treatment of social anxiety disorder: a randomized controlled trial. Behav Res Ther. 2016;77:147–56. This study shows that VRET can be effective without additional cognitive components for social fears, comparing a VRET condition to an iVET condition in an individual approach, and including extensive virtual verbal interaction PubMedCrossRef

23.

Scholing A, Emmelkamp PMG. Exposure with and without cognitive therapy for generalized social phobia: effects of individual and group treatment. Behav Res Ther. 1993;31:667–81.PubMedCrossRef

24.

Hofmann SG, Otto MW. Cognitive-behavior therapy of social anxiety disorder: evidence-based and disorder specific treatment techniques. New York: Routledge; 2008.

25.

Malbos E, Rapee RM, Kavakli M. A controlled study of agoraphobia and the independent effect of virtual reality exposure therapy. Aust N Z J Psychiatry. 2013;47:160–8.PubMedCrossRef

26.

Barlow DH. Clinical handbook of psychological disorders. New York: The Guilford Press; 2007.

27.

Beck AT, Emery G. Anxiety disorders and phobias: a cognitive perspective. New York: Basic Books; 1985.

28.

Craske MG. Anxiety disorders: psychological approaches to theory and treatment. Boulder: Westview Press; 1999.

29.

Meyerbroeker K, Morina N, Kerkhof GA, Emmelkamp PMG. Virtual reality exposure therapy does not provide any additional value in agoraphobic patients: a randomized controlled trial. Psychother Psychosom. 2013;82:170–6.PubMedCrossRef

30.

Craske MG, Barlow DH. Mastery of anxiety and panic. 4th ed. Oxford: Oxford University Press; 2007.

31.

Moldovan R, David D. One session treatment of cognitive and behavioral therapy and virtual reality for social and specific phobias. Preliminary results from a randomized clinical trial. J Evidence-Based Psychother. 2014;14:67–83.

32.

Pelissolo A, Zaoui M, Aguayo G, Yao SN, Roche S, Ecochard R, et al. Virtual reality exposure therapy versus cognitive behavior therapy for panic disorder with agoraphobia: a randomized comparison study. J CyberTherapy Rehabil. 2012;5:35–43.

33.

Cottraux J, Bouvard M, Légeron P. Méthodes et échelles d’évaluation des comportements. Editions d. Issy les Moulineaux: Editions d’Application Psychotechniques; 1985.

34.

Landon TM, Barlow DH. Cognitive-behavioral treatment for panic disorder: current status. J Psychiatr Pract. 2004;10:211–26.PubMedCrossRef

35.

Castro WP, Roca Sánchez MJ, Pitti González CT, Bethencourt JM, de la Fuente Portero JA, Marco RG. Cognitive-behavioral treatment and antidepressants combined with virtual reality exposure for patients with chronic agoraphobia. Int J Clin Health Psychol. 2014;14:9–17.CrossRef

36.

Pitti CT, Peñate W, De La Fuente J, Bethencourt JM, Roca-Sánchez MJ, Acosta L, et al. The combined use of virtual reality exposure in the treatment of agoraphobia. Actas Esp Psiquiatr. 2015;4343:133–41133.

37.

Triscari MT, Faraci P, Catalisano D, D’Angelo V, Urso V. Effectiveness of cognitive behavioral therapy integrated with systematic desensitization, cognitive behavioral therapy combined with eye movement desensitization and reprocessing therapy, and cognitive behavioral therapy combined with virtual reality expo. Neuropsychiatr Dis Treat. 2015;11:2591–8.PubMedPubMedCentral

38.

Heeter C. Being there: the subjective experience of presence. Presence Teleop Virt Environ. 1992;1:262–71.CrossRef

39.

Lee KM. Presence, explicated. Commun Theory. 2004;14:27–50.CrossRef

40.

Lombard M, Ditton T. At the heart of it all: the concept of presence. J Comput Commun. Blackwell Publishing Ltd; 2006;3.

41.

McMahan A. Immersion, engagement, and presence: a method for analyzing 3-D video games. In: Wolf MJP, Bernard P, editors. Journal of anxiety disorders. New York: Routledge; 2003. p. 67–86.

42.

Slater M, Wilbur S. A framework for immersive virtual environments (FIVE): speculations on the role of presence in virtual environments. Presence Teleop Virtual Environ. 1997;6:603–16.CrossRef

43.

Steuer J. Defining virtual reality: dimensions determining telepresence. Aust J Commun. 1992;42:73–93.CrossRef

44.

Witmer BG, Singer MJ. Measuring presence in virtual environments: a presence questionnaire. Presence Teleoper Virtual Environ. 1998;7:225–40.CrossRef

45.

Diemer J, Alpers GW, Peperkorn HM, Shiban Y, Mühlberger A. The impact of perception and presence on emotional reactions: a review of research in virtual reality. Front Psychol. 2015;6:1–9.CrossRef

46.

Botella C, Osma J, Garcia-Palacios A, Quero S, Baños RM. Treatment of flying phobia using virtual reality: data from a 1-year follow-up using a multiple baseline design. Clin Psychol Psychother. 2004;11:311–23.CrossRef

47.

Schubert T, Friedmann F, Regenbrecht H. The experience of presence: factor analytic insights. Presence Teleop Virtual Environ. 2001;10:266–81.CrossRef

48.

Sheridan TB. Descartes, Heidegger, Gibson, and god: toward an eclectic ontology of presence. Presence Teleop Virtual Environ. 1999;8:551–9.CrossRef

49.

Schuemie MJ, van der Straaten P, Krijn M, van der Mast CAPG. Research on presence in virtual reality: a survey. CyberPsychology Behav. 2001;4:183–201.CrossRef

50.

Regenbrecht HT, Schubert TW, Friedmann F. Measuring the sense of presence and its relations to fear of heights in virtual environments. Int J Hum Comput Interact. 1998;10:233–49.CrossRef

51.

Robillard G, Bouchard S, Fournier T, Renaud P. Anxiety and presence during VR immersion: a comparative study of the reactions of phobic and non-phobic participants in therapeutic virtual environments derived from computer games. CyberPsychology Behav. 2003;6:467–76.CrossRef

52.

Rothbaum BO, Hodges LF, Kooper R, Opdyke D, Williford JS, North M. Effectiveness of computer-generated (virtual reality) graded exposure in the treatment of acrophobia. Am J Psychiatry. 1995;152:626–8.PubMedCrossRef

53.

Wiederhold BK, Wiederhold MD. The effect of presence on virtual reality treatment. In: virtual reality therapy for anxiety disorders: advances in evaluation and treatment. Washington: American Psychological Association; 2005.CrossRef

54.

Krijn M, Emmelkamp PM, Biemond R, de Wilde de Ligny C, Schuemie MJ, van der Mast CAP. Treatment of acrophobia in virtual reality: the role of immersion and presence. Behav Res Ther. 2004;42:229–39.PubMedCrossRef

55.

Price M, Mehta N, Tone EB, Anderson PL. Does engagement with exposure yield better outcomes? Components of presence as a predictor of treatment response for virtual reality exposure therapy for social phobia. J Anxiety Disord. 2011;25:763–70.PubMedPubMedCentralCrossRef

56.

Price M, Anderson P. The role of presence in virtual reality exposure therapy. J Anxiety Disord. 2007;21:742–51.PubMedCrossRef

57.

Schuemie MJ, Bruynzeel M, Drost L, Brinckman M, De Haan G, et al. Treatment of acrophobia in virtual reality: a pilot study. In: Broeckx, F, Pauwels L. (Eds.) Conference Proceedings Euromedia 2000 May 8–10; Antwerp, Belgium. Ostend, Belgium: EUROSIS – ETI Publications. p. 271–275.

58.

Walshe D, Lewis E, O’Sullivan K, Kim SI. Virtually driving: are the driving environments “real enough” for exposure therapy with accident victims? An explorative study. Cyberpsychol Behav. 2005;8:532–7.PubMedCrossRef

59.

Kim K, Kim C-H, Cha KR, Park J, Han K, Kim YK, et al. Anxiety provocation and measurement using virtual reality in patients with obsessive-compulsive disorder. CyberPsychology Behav. 2008;11:637–41.CrossRef

60.

Ling Y, Brinkman W-P, Nefs HT, Qu C, Heynderickx I. Effects of stereoscopic viewing on presence, anxiety, and cybersickness in a virtual reality environment for public speaking. Presence Teleoper Virtual Environ. 2012;21:254–67.CrossRef

61.

Villani D, Repetto C, Cipresso P, Riva G. May I experience more presence in doing the same thing in virtual reality than in reality? An answer from a simulated job interview. Interact Comput Oxford University Press. 2012;24:265–72.CrossRef

62.

Peperkorn HM, Diemer J, Mühlberger A. Temporal dynamics in the relation between presence and fear in virtual reality. Comput Hum Behav. 2015;48:542–7.CrossRef

63.

Bouchard S, St-Jacques J, Robillard G, Renaud P. Anxiety increases the feeling of presence in virtual reality. Presence Teleoper Virtual Environ. 2008;17:376–91.CrossRef

64.

Baños R, Botella C, Liaño V, Guerrero B, Rey B, Alcañiz M. Sense of presence in emotional virtual environments. Presence. 2004:156–9.

65.

Cummings JJ, Bailenson JN. How immersive is enough? A meta-analysis of the effect of immersive technology on user presence. 2015;1–38.

66.

Fitzgerald PJ, Seemann JR, Maren S. Can fear extinction be enhanced? A review of pharmacological and behavioral findings. Brain Res Bull. 2014;105:46–60.PubMedCrossRef

67.

McGuire JF, Lewin AB, Storch EA. Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder. Expert Rev Neurother. 2014;14:893–910.PubMedPubMedCentralCrossRef

68.

Hofmann SG, Otto MW, Pollack MH, Smits JA. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update. Curr Psychiatry Rep. 2015;17:532.PubMedCrossRef

69.

• Mataix-Cols D, Fernández de la Cruz L, Monzani B, Rosenfield D, Andersson E, Pérez-Vigil A, et al. D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders. JAMA Psychiatry. 2017;22:1–10. This IPD meta-analysis synthesizes evidence for the role of DCS in enhancing exposure-based therapy for several disorders. DCS shows great improvement from pre-treatment to post-treatment, but not from pre-treatment to follow-up. Apart from the year of publication, no other moderator is found

70.

Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, et al. Cognitive enhancers as adjuncts to psychotherapy. Arch Gen Psychiatry. 2004;61:1136.PubMedCrossRef

71.

Tart CD, Handelsman PR, DeBoer LB, Rosenfield D, Pollack MH, Hofmann SG, et al. Augmentation of exposure therapy with post-session administration of d-cycloserine. J Psychiatr Res. 2013;47:168–74.PubMedCrossRef

72.

Meyerbroeker K, Powers MB, Van Stegeren A, Emmelkamp PMG. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial. Psychother Psychosom. 2012;81:29–37.PubMedCrossRef

73.

de Quervain DJ-F, Bentz D, Michael T, Bolt OC, Wiederhold BK, Margraf J, et al. Glucocorticoids enhance extinction-based psychotherapy. Proc Natl Acad Sci. 2011;108:6621–5.PubMedPubMedCentralCrossRef

74.

•• Shiban Y, Pauli P, Mühlberger A. Effect of multiple context exposure on renewal in spider phobia. Behav Res Ther. 2013;51:68–74. This study shows how changing the context during exposure can be important in reducing the return of fear at post treatment, even when the same results are not found at follow-up PubMedCrossRef

75.

Shiban Y, Peperkorn H, Alpers GW, Pauli P, Mühlberger A. Influence of perceptual cues and conceptual information on the activation and reduction of claustrophobic fear. J Behav Ther Exp Psychiatry. 2016;51:19–26.PubMedCrossRef

76.

Shiban Y, Brütting J, Pauli P, Mühlberger A. Fear reactivation prior to exposure therapy: does it facilitate the effects of VR exposure in a randomized clinical sample? J Behav Ther Exp Psychiatry. 2015;46:133–40.PubMedCrossRef

77.

Shiban Y, Fruth MB, Pauli P, Kinateder M, Reichenberger J, Mühlberger A. Treatment effect on biases in size estimation in spider phobia. Biol Psychol. 2016;121:146–52.PubMedCrossRef

78.

Meyerbröker K, Emmelkamp PMG. Virtual reality exposure therapy in anxiety disorders: a systematic review of process-and-outcome studies. Depress Anxiety. 2010;27:933–44.PubMedCrossRef

79.

Page S, Coxon M. Virtual reality exposure therapy for anxiety disorders: small samples and no controls? Front Psychol. 2016;7:1–4.CrossRef

80.

McCann RA, Armstrong CM, Skopp NA, Edwards-Stewart A, Smolenski DJ, June JD, et al. Virtual reality exposure therapy for the treatment of anxiety disorders: an evaluation of research quality. J Anxiety Disord. 2014;28(6):625–31.PubMedCrossRef

81.

Fleming TM, de Beurs D, Khazaal Y, Gaggioli A, Riva G, Botella C, et al. Maximizing the impact of e-therapy and serious gaming: time for a paradigm shift. Front psychiatry. 2016;7:65.PubMedPubMedCentralCrossRef

82.

Wrzesien M, Bretón-López J, Botella C, Burkhardt J-M, Alcañiz M, Pérez-Ara MA, et al. How technology influences the therapeutic process: evaluation of the patient-therapist relationship in augmented reality exposure therapy and in vivo exposure therapy. Behav Cogn Psychother. 2013;41:505–9.PubMedCrossRef

83.

Wrzesien M, Botella C, Bretón-López J, Del Río Ganzález E, Burkhardt J-MM, Alcañiz M, et al. Treating small animal phobias using a projective-augmented reality system: a single-case study. Comput Hum Behav. 2015;49:343–53.CrossRef

84.

• Bailey JO, Bailenson JN. Considering virtual reality in children’s lives. J Child Media. 2017;11:107–13. This review describes the potential of a practically unexplored area in virtual reality, its application to children CrossRef

85.

Riva G, Baños RM, Botella C, Mantovani F, Gaggioli A. Transforming experience: the potential of augmented reality and virtual reality for enhancing personal and clinical change. Front Psychiatry. 2016;7:1–14.CrossRef

86.

Grenier S, Forget H, Bouchard S, Isere S, Belleville S, Potvin O, et al. Using virtual reality to improve the efficacy of cognitive-behavioral therapy (CBT) in the treatment of late-life anxiety: preliminary recommendations for future research. Int Psychogeriatr. 2015;27:1217–25.PubMedCrossRef

87.

Raghav K, Van Wijk AJ, Abdullah F, Islam MN, Bernatchez M, De Jongh A. Efficacy of virtual reality exposure therapy for treatment of dental phobia: a randomized control trial. BMC Oral Health. 2016;16:25.PubMedPubMedCentralCrossRef

88.

Miloff A, Lindner P, Hamilton W, Reuterskiöld L, Andersson G, Carlbring P. Single-session gamified virtual reality exposure therapy for spider phobia vs. traditional exposure therapy: study protocol for a randomized controlled non-inferiority trial. Trials. 2016;17:60.PubMedPubMedCentralCrossRef

89.

Rozental A, Magnusson K, Institutet K, Boettcher J, Andersson G, Carlbring P. For better or worse: an individual patient data meta-analysis of deterioration among participants receiving Internet-based cognitive behavior therapy. J Consuling Clin Psychol. 2017;85:160–77.CrossRef

90.

Lambert MJ. Handbook of psychotherapy and behavior change. Sixth ed. New Jersey: Wiley Blackwell; 2013.

91.

• Lindner P, Miloff A, Hamilton W, Reuterskiöld L, Andersson G, Powers M, Carlbring P. Creating state of the art, next-generation Virtual reality exposure therapies for anxiety disorders using consumer hardware platforms: design considerations and future direction. Cogn Behav Ther; 2017. It reviews the current state of VR technology and analyzes the possibilities of using low-cost commercially available VR hardware. Challenges in the development, evaluation, and dissemination of VRET applications are discussed.

92.

Kazdin AE, Blase SL. Rebooting psychotherapy research and practice to reduce the burden of mental illness. Perspect Psychol Sci. 2011;6:21–37.

93.

Mitroff SR, Biggs AT, Adamo SH, Dowd EW, Winkle J, Clark K. What can 1 million trials tell us about visual search? Psychol Sci. 2015;41:1–5.

94.

Cárdenas G, Botella C, Quero S, Baños R, Durán X, De Rosa A, et al. Efectividad del programa de tratamiento virtual flight con población mexicana effectiveness of the treatment program virtual flight with mexican population. Rev Argen Clin Psic. 2016;25:145–56.

95.

Aymerich-Franch L, Kizilcec RF, Bailenson JN. The relationship between virtual self similarity and social anxiety. Front hum Neurosci. Frontiers. 2014;8:944.

96.

Bailenson JN. Doppelgangers—a new form of self? Psychologist. 2012;25:36–8.

97.

Miragall M, Baños RM, Cebolla A, Botella C. Working alliance inventory applied to virtual and augmented reality (WAI-VAR): psychometrics and therapeutic outcomes. Front Psychol. 2015;6:1–10.CrossRef

Titel: Recent Progress in Virtual Reality Exposure Therapy for Phobias: A Systematic Review
verfasst von: Cristina Botella
Javier Fernández-Álvarez
Verónica Guillén
Azucena García-Palacios
Rosa Baños
Publikationsdatum: 01.07.2017
Verlag: Springer US
Erschienen in: Current Psychiatry Reports / Ausgabe 7/2017
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI: https://doi.org/10.1007/s11920-017-0788-4

Neu im Fachgebiet Psychiatrie

18.04.2024 | Arterielle Hypertonie | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Recent Progress in Virtual Reality Exposure Therapy for Phobias: A Systematic Review

Abstract

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2017

Anticipating the Ethical Challenges of Psychiatric Genetic Testing

Addressing the Needs of Preschool Children in the Context of Disasters and Terrorism: Clinical Pictures and Moderating Factors

Addressing the Needs of Preschool Children in the Context of Disasters and Terrorism: Assessment, Prevention, and Intervention

Psychiatric Illness and Parasomnias: a Systematic Review

Brain-Derived Neurotrophic Factor Expression in Individuals With Schizophrenia and Healthy Aging: Testing the Accelerated Aging Hypothesis of Schizophrenia

Autism Spectrum Disorder in Anorexia Nervosa: An Updated Literature Review

Neu im Fachgebiet Psychiatrie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Psychiatrie